The Norwegian delegation at the booth coordinated by OCC at Nordic Life Science Days 2023 in Copenhagen, Denmark

Nordic Life Science Days 2023

This year’s Nordic Life Science Days took place in Copenhagen on 29-30 November.

Since 2015, Oslo Cancer Cluster has coordinated the joint booth Norway for Life Science, promoting the Norwegian healthcare and life science industry. This year together with Norway Health Tech, The Life Science Cluster, Norwegian Smart Care Cluster, Centre for Digital Life Norway, NorTrials, Aleap, Legemiddelindustrien (LMI), Inven2, Innovation Norway, the Royal Norwegian Embassy in Copenhagen and Curida.

 

The Oslo Cancer Cluster team representing and networking in Copenhagen. From Left: Charlotte Homme, Dave Tippett, Thomas Andersson (Business Development, OCC Incubator), Janne Nestvold (COO, OCC Incubator) and Bente Prestegård.

Our members on stage

Anette Weyergang, CEO at RAB Diagniostics, a new company that works towards making cancer treatment more effective and match the right patient with the right drug. RAB Diagniostics is a part of Oslo Cancer Clusters Incubator accelerator program which provide the project with business development.

 RAB diagnostics Anette Weyergang at Nordic Life Science Days 2023 in Copenhagen

RAB diagnostics CEO Anette Weyergang at Nordic Life Science Days 2023 in Copenhagen.

 

Weyergang is a pharmacist by education and has spent her career since 2004 in Professor Kristian Berg’s research group at the Institute for Cancer Research.

It was great fun pitching RAB Diagniostics in this environment at NLS days, I wish I had more than 4 minutes on stage to talk about our ongoing mission, which is to help finding the right patients so that we can spare those who are less likely to respond to unnecessary treatments.

Find more information about RAB Diagnostics here

 

Adam Robertson CEO at Hemispherian, pitching at NLSDays 2023.

Adam Robertson, Chief Scientific Officer at Hemispherian, was thrilled to present at Nordic Life Science days. Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs.

Presenting at NLS Days was an exciting experience. I am glad that so many participants were able to attend. Being a part of such high calibre pitches is hugely motivating.

Hemispherian is at the forefront of revolutionizing cancer treatment, offering hope and potential solutions for patients facing hard-to-treat cancers, especially glioblastoma. The company will enter clinical development in 2024. Robertson shares that Hemispherian’s drug candidates have shown excellent efficacy including in orthotopic glioblastoma xenograft models, as well as excellent tolerability in several animal models.

Find more information about Hemispherian here

 

 

Torbjørn Furuseth, CEO and Co-founder of DoMore Diagnostics.

Torbjørn Furuseth, CEO and co-founder of DoMore! Diagnostics, presented the latest development and new results from tthis years research and projects.

Find more information about DoMore! Diagnostics here

 

Hanne Lund, Business Development Director at Curida pitching on stage at NLS Days.

Hanne Lund, Business Development Director at Curida, talked about the newest updates from the company in 2023.

Find more information about Curida here

 

 

 

The post Nordic Life Science Days 2023 first appeared on Oslo Cancer Cluster.

Thomas Andersson, Business Development Adviser in Oslo Cancer Cluster Incubator, is one of the health mentors in the new scheme from Innovation Norway to help health startups to grow.

Find your health mentor

Thomas Andersson, Senior Adviser, Business Development, Oslo Cancer Cluster Incubator

Oslo Cancer Cluster Incubator has joined a new national health mentor program to help Norwegian startups connect with the right experts.

Are you a health startup? Do you need help to get going? Eight health clusters and incubators have joined forces to provide mentors and specialist knowledge to Norwegian health startups, through the new health mentor program from Innovation Norway. One of them is Oslo Cancer Cluster Incubator.

Bjørn Klem, general manager of Oslo Cancer Cluster Incubator, commented:

“Innovation Norway’s new health mentor program is a good scheme for startups that need help to establish their company. Access to a network of health mentors give the companies the opportunity to get tailor-made guidance in a very challenging development phase.”

This is the first time Innovation Norway offers a mentor program for a specific industry. The scheme is a pilot project for year 2020. Bård Stranheim, responsible for the mentor program in Innovation Norway, said:

“Good mentors are an important key to growth. This scheme will give high-quality mentors. Maybe this pilot project will be the basis of a new model to connect world-class mentors with Norwegian startups to prepare them for international growth.”

 

The health mentor program consists of:

 

Apply on Innovation Norway’s website for a health mentor

 

Sign up to our monthly newsletter